Courage Therapeutics

Courage Therapeutics is a preclinical-stage biopharmaceutical company focused on treating obesity and eating disorders. The company is led by a team of experienced scientists and pharmaceutical industry experts, concentrating on developing scientific discoveries related to the brain's response to the body's energy signals. The company has signed a licensing agreement with the University of Michigan to develop treatments based on a portfolio of intellectual property co-invented by Courage.